US Researchers Create 16 AI-Designed Viruses

U.S. scientists announced that they have engineered 16 viral genomes using artificial‑intelligence algorithms, a development that could accelerate vaccine and antiviral research but also raises significant biosecurity concerns. The work, conducted by a team at a leading research university, employed machine‑learning models trained on publicly available viral sequence data to design novel variants that mimic key pathogenic features while lacking harmful traits.

The researchers claim the AI‑generated viruses will serve as test platforms for evaluating immune responses and drug efficacy, potentially shortening the timeline for developing countermeasures against emerging pathogens. However, experts in biosafety and bioethics warn that the same technology could be exploited to create more transmissible or drug‑resistant strains, underscoring the need for stringent oversight, secure data handling, and transparent peer review before any broader application.

The study has sparked a debate about balancing scientific progress with national and global security. While the potential medical benefits are substantial, regulators and the scientific community are calling for clear guidelines and international cooperation to prevent misuse of AI‑driven virology.